Perlmutter NYU Cancer Center ( Site 1212) — New York, New York

Perlmutter NYU Cancer Center ( Site 1212) is a clinical research site located in New York, New York, United States 10016.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

Perlmutter NYU Cancer Center ( Site 1212) has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Gastrointestinal Cancer.

Sponsors: Merck Sharp & Dohme LLC.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Perlmutter NYU Cancer Center ( Site 1212)?

Perlmutter NYU Cancer Center ( Site 1212) has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Perlmutter NYU Cancer Center ( Site 1212) conducted?

Perlmutter NYU Cancer Center ( Site 1212) has 1 clinical trials on record, with 1 currently active. Their work covers Gastrointestinal Cancer.

Is Perlmutter NYU Cancer Center ( Site 1212) accredited by Crixeo Health?

Perlmutter NYU Cancer Center ( Site 1212) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Perlmutter NYU Cancer Center ( Site 1212)?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.